与瘤相关的IDH1突变体中的活性部位重塑驱动着独特的动力特征和潜在的抵抗机制
Matthew Mealka1, Nicole A Sierra1, Diego Avellaneda Matteo1
1Department of Chemistry & Biochemistry, San Diego State University, San Diego, CA, USA.
Nature communications
|May 6, 2024
概括
人体异酸脱酶1 (IDH1) 中的突变通过创建一个新的功能,导致癌症. 在R132Q突变IDH1显示独特的结构变化,改善正常和癌症驱动活动.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
背景情况:
- 人体异酸脱酶1 (IDH1) 中的突变是各种癌症的驱动因素.
- IDH1突变赋予新型活性,产生一种促进瘤形成的代代体.
- 对于IDH1突变体之间的机制差异仍然不太了解.
研究的目的:
- 为了研究导致瘤的IDH1突变体之间的机制差异.
- 将R132Q突变的反应机制与其他突变进行比较,R132Q突变保留了常规活性,同时产生代谢物.
- 了解IDH1突变如何导致癌症和治疗耐药性.
主要方法:
- 使用静态和动态结构方法.
- 分析了活性部位的形状和基质结合.
- 评估了化物转移效率.
主要成果:
- R132Q IDH1活性部位采用了针对催化最优化的形状.
- 与R132H突变相比,R132Q表现出增强的基质结合和化物转移.
- 与R132H相比,R132Q表现出比R132H更好的常规和新型活性.
- 在R132Q中观察到活性部位的重塑,这可能解释了对IDH1抑制剂的耐药性.
结论:
- IDH1活性位点的结构可塑性会影响其催化活动.
- 了解IDH1活性部位重塑对于开发有效的癌症疗法至关重要.
- 这项研究提供了关于IDH1机制的见解,并确定了改善抑制剂选择性的目标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K


